DiaSorin

ASPR's IBx Portfolio

Product: Antigen Tests

Description of Project: This contract was awarded to DiaSorin Inc. to increase its production capacity of LIAISON SARS-CoV-2 TrimericS IgG tests.

Unique Impact: This industrial base expansion effort will allow DiaSorin Inc. to increase its production capacity of LIAISON SARS-CoV-2 TrimericS IgG tests from 1.3 million tests per month to 10 million per month by May 2022.

Base Award Amount: $4,624,729.00

Category: Testing Capacity and Raw Materials